Deborah J. Wexler

16.5k total citations · 4 hit papers
167 papers, 10.9k citations indexed

About

Deborah J. Wexler is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Deborah J. Wexler has authored 167 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Physiology and 21 papers in Molecular Biology. Recurrent topics in Deborah J. Wexler's work include Diabetes Treatment and Management (79 papers), Diabetes Management and Research (66 papers) and Diabetes Management and Education (27 papers). Deborah J. Wexler is often cited by papers focused on Diabetes Treatment and Management (79 papers), Diabetes Management and Research (66 papers) and Diabetes Management and Education (27 papers). Deborah J. Wexler collaborates with scholars based in United States, Germany and Canada. Deborah J. Wexler's co-authors include John B. Buse, Geltrude Mingrone, Melanie J. Davies, Chantal Mathieu, Peter Rossing, Απόστολος Τσάπας, David A. D’Alessio, Walter N. Kernan, Judith Fradkin and James B. Meigs and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Deborah J. Wexler

160 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2018 2.6k citations Melanie J. Davies, David A. D’Alessio et al. Diabetes Care profile →
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2018 1.1k citations Melanie J. Davies, David A. D’Alessio et al. Diabetologia profile →
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2019 834 citations John B. Buse, Deborah J. Wexler et al. Diabetes Care profile →
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2019 352 citations John B. Buse, Deborah J. Wexler et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah J. Wexler United States	45	7.6k	2.3k	1.7k	1.6k	1.3k	167	10.9k
Antonio Nicolucci Italy	61	7.0k 0.9×	1.1k 0.5×	1.8k 1.0×	2.6k 1.7×	1.6k 1.3×	324	13.3k
M. Sue Kirkman United States	40	7.4k 1.0×	1.3k 0.6×	2.5k 1.4×	1.4k 0.9×	609 0.5×	70	11.1k
Sophia Zoungas Australia	60	7.2k 0.9×	1.7k 0.7×	2.6k 1.5×	1.6k 1.0×	614 0.5×	290	14.8k
Robert A. Gabbay United States	44	5.0k 0.7×	1.2k 0.5×	1.4k 0.8×	1.2k 0.7×	1.1k 0.8×	138	7.8k
Zachary T. Bloomgarden United States	44	5.9k 0.8×	2.1k 0.9×	2.2k 1.3×	1.1k 0.7×	363 0.3×	264	9.5k
Catherine C. Cowie United States	50	9.1k 1.2×	1.9k 0.8×	2.1k 1.2×	2.7k 1.7×	1.4k 1.1×	113	16.0k
Ambady Ramachandran India	54	8.4k 1.1×	1.4k 0.6×	1.4k 0.8×	3.0k 1.9×	1.0k 0.8×	207	13.3k
Sharon Saydah United States	50	7.9k 1.0×	1.5k 0.6×	2.5k 1.4×	1.9k 1.2×	1.5k 1.2×	158	14.5k
Theodore J. Thompson United States	35	4.9k 0.6×	944 0.4×	1.1k 0.6×	1.7k 1.1×	1.5k 1.2×	75	10.3k
Alexandra Kautzky‐Willer Austria	52	3.6k 0.5×	1.7k 0.8×	2.4k 1.4×	1.8k 1.1×	447 0.4×	461	11.3k

Countries citing papers authored by Deborah J. Wexler

Since Specialization

Citations

This map shows the geographic impact of Deborah J. Wexler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah J. Wexler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah J. Wexler more than expected).

Fields of papers citing papers by Deborah J. Wexler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah J. Wexler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah J. Wexler. The network helps show where Deborah J. Wexler may publish in the future.

Co-authorship network of co-authors of Deborah J. Wexler

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah J. Wexler. A scholar is included among the top collaborators of Deborah J. Wexler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah J. Wexler. Deborah J. Wexler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blood, Alexander, Lee‐Shing Chang, Joshua Noone, et al.. (2025). Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies. American Heart Journal. 282. 114–124. 2 indexed citations

Tesfaye, Helen, Julie M. Paik, Deborah J. Wexler, et al.. (2025). GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population‐based study. Diabetes Obesity and Metabolism. 28(2). 1517–1528. 1 indexed citations

Paik, Julie M., et al.. (2025). Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes. Diabetes Care. 48(12). 2127–2137.

Kalyani, Rita R., Joshua J. Neumiller, Nisa M. Maruthur, & Deborah J. Wexler. (2025). Diagnosis and Treatment of Type 2 Diabetes in Adults. JAMA. 334(11). 984–984. 7 indexed citations

Crisafulli, Salvatore, Wajd Alkabbani, Julie M. Paik, et al.. (2025). Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes. Annals of Internal Medicine. 179(1). 1–11.

Chang, Lee‐Shing, et al.. (2024). Enrollment strategies in the era of digital revolution: Experience from a remote health management program. American Heart Journal. 278. 181–185. 2 indexed citations

Fu, Edouard L., Deborah J. Wexler, Sara J. Cromer, et al.. (2024). SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study. BMJ. 385. e078483–e078483. 10 indexed citations

Blood, Alexander, Lee‐Shing Chang, Samuel Aronson, et al.. (2024). Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial. Circulation. 149(23). 1802–1811. 10 indexed citations

Schneeweiß, Sebastian, Robert J. Glynn, Deborah J. Wexler, et al.. (2024). Bariatric surgery and all‐cause mortality: A methodological review of studies using a non‐surgical comparator. Diabetes Obesity and Metabolism. 26(10). 4273–4280.

10.

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2024). Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia. 67(7). 1328–1342. 8 indexed citations

11.

Whittemore, Robin, Marcella Nuñez-Smith, Christopher M. Lee, et al.. (2023). Self-Management and Glycemic Targets in Adult Haitian Immigrants With Type 2 Diabetes. Nursing Research. 72(3). 211–217. 1 indexed citations

12.

D’Andrea, Elvira, et al.. (2023). Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA_1c Levels. JAMA Internal Medicine. 183(3). 242–242. 55 indexed citations

13.

Desai, Rishi, Robert J. Glynn, Brendan M. Everett, et al.. (2022). Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care. American Heart Journal. 254. 203–215. 12 indexed citations

14.

Antal, Botond, Syed Fahad Sultan, Deborah J. Wexler, et al.. (2022). Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. eLife. 11. 112 indexed citations

15.

Patorno, Elisabetta, Robert J. Glynn, Sebastian Schneeweiß, et al.. (2021). Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Annals of Internal Medicine. 174(11). 1528–1541. 65 indexed citations

16.

Buse, John B., Deborah J. Wexler, Απόστολος Τσάπας, et al.. (2019). 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 63(2). 221–228. 352 indexed citations breakdown →

17.

Kazemian, Pooyan, et al.. (2019). Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. 21(6). 344–355. 10 indexed citations

18.

Patorno, Elisabetta, Ajinkya Pawar, Jessica M. Franklin, et al.. (2019). Abstract 11928: Cardiovascular Effectiveness of Empagliflozin Compared to DPP4 Inhibitors and to GLP1 Receptor Agonists: Interim Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study. Circulation. 1 indexed citations

19.

Wexler, Deborah J., Camille E. Powe, Linda A. Barbour, et al.. (2018). Research Gaps in Gestational Diabetes Mellitus. Obstetrics and Gynecology. 132(2). 496–505. 55 indexed citations

20.

Gonzalez, Jeffrey S., Steven A. Safren, Enrico Cagliero, et al.. (2007). Depression, Self-Care, and Medication Adherence in Type 2 Diabetes. Diabetes Care. 30(9). 2222–2227. 430 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact